跳至主要内容
临床试验/JPRN-UMIN000027859
JPRN-UMIN000027859已完成未知

Examination of the treatment prediction factor of Ombitasvir/Paritaprevir/Ritonavir in chronic hepatitis C of Genotype1b. - Examination of the treatment prediction factor of Ombitasvir/Paritaprevir/Ritonavir in chronic hepatitis C of Genotype1b.

ippon Medical School Chiba Hokusoh Hospital0 个研究点目标入组 500 人开始时间: 2017年6月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.History of allergy to Ombitasvir/Paritaprevir/Ritonavir 2.Decompensated liver cirrhosis 3.pregnant woman or lactating mother 4.Hepatocellular carcinoma, or other malignant tumor. 5.severe depression 6.Judged by investigator not to be appropriate for inclusion in this study 7.Receiving contraindicated drugs for Ombitasvir/Paritaprevir/Ritonavir combined therapy

研究者

发起方
ippon Medical School Chiba Hokusoh Hospital

相似试验